Sinocelltech Group Ltd (688520 SHG) stock market data APIs
¥51.8991
-0.17(-0.3%)
as of November 14, 2025
Try our APIs with
free plan!
Sinocelltech Group Ltd Financial Data Overview
Price chart is built with
Anychart
Sinocelltech Group Limited, a biopharmaceutical company, engages in the research and development and production of recombinant proteins, antibody drugs, and vaccines in China. The company offers Anpingxi, an antibody drug and anti-tumor product; Anjiayin for the treatment of hemophilia A; coronavirus 2-valent, a trimer protein vaccine; and SCTV01C and SCTV01E, which are mutant strain recombinant protein vaccines. Its product pipeline includes SCT630 used for the treatment of autoimmune diseases; SCT510 for treating solid tumors; SCT-I10A, a monoclonal antibody injection, which is in phase 3 trials for the treatment of solid tumors; SCTV01 vaccine for the treatment of corona virus; SCT200, a monoclonal antibody injection for the treatment of solid tumors; and SCT1000 for the treatment of human papillomavirus, as well as SCTA01, which is in phase 2/3 clinical research trials for treating SARS COV-2. The company was founded in 2002 and is based in Beijing, China. Sinocelltech Group Limited is a subsidiary of Lhasa Alike Investment Consulting Co., Ltd.
Prev. Close
51.8991
Open
51.726
High
52.5471
Low
50.9027
52 wk Range
33.5-89.04
Market Cap
23 019 M
Shares Outstanding
445 M
Revenue
1 888 M
EPS
-0.2651
Beta
0.878
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Sinocelltech Group Ltd (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Sinocelltech Group Ltd data using free add-ons & libraries
Get Sinocelltech Group Ltd Fundamental Data
Sinocelltech Group Ltd Fundamental data includes:
- Net Revenue: 1 888 M
- EBITDA: 19 505 K
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2023-04-25
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Sinocelltech Group Ltd News
New
Sinocelltech Group And 2 More High Growth Tech Stocks In Asia
In recent weeks, Asian markets have shown resilience with the CSI 300 Index and Shanghai Composite Index posting gains, despite ongoing challenges such as China's persistent deflation pressures and a ...
Qiming's Portfolio Company InventisBio Lists on STAR Market
SHANGHAI, July 25, 2022 /PRNewswire/ -- Qiming Venture Partners' portfolio company InventisBio (SHSE: 688382), a leading company in innovative drug development, today listed on the Science and Technol...
Qiming Venture Partners Announces Closing of Funds Totaling US$3.2 Billion
SHANGHAI, July 11, 2022 /PRNewswire/ -- Qiming Venture Partners announced today the closing of its latest funds totaling US$3.2 billion, including USD Fund VIII at US$2.5 billion and the first closing...
Qiming's Nisa Leung, Duane Kuang Named on 2022 Forbes Midas List
SHANGHAI, April 12, 2022 /PRNewswire/ – Forbes released the 2022 Midas List on April 12, a ranking of the world's top 100 venture capitalists. Nisa Leung, Managing Partner of Qiming Venture Partners...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
